COVID-19 Science & Society: Recent Episodes

Virology Education

How will the world look like in 2022? Is SARS-CoV-2 here to stay with us? While some countries are opening towards normal life, albeit with cautious optimism, others are experiencing the hardest disease burden and public health crisis so far. Will vaccines be effective against new variants and how long the protection will last? What do we know so far about long COVID? Which patient populations could benefit most from emerging therapeutic options? Would there be resistance to new therapies? Subscribe to the COVID-19 Science & Society podcast to find out more on the most relevant and timely topics concerning the COVID pandemic.

View Details

Ravindra Gupta, MA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSciUniversity of Cambridge,
United Kingdom

View Details

Laura Waters, MD, FRCPCentral & North West London NHS Foundation Trust, 
United Kingdom

View Details

Monica Gandhi, MD, MPH
University of California San Francisco, 
United States

View Details

Jean Nachega MD, PhD, MPH, FRCP, FAAS
University of Pittsburgh / Johns Hopkins University, United States
Stellenbosch University, South Africa

View Details

Karine Lacombe, MD, PhD
Hôpital Saint Antoine Paris, France

View Details

Michel Kazatchkine, MDThe Global Health Center, Graduate Institute for International Affairs and Development

References:
The Independent Panel for Pandemic Preparedness & Response 

View Details

Kathryn Stephenson, MD, MPHBeth Israel Deaconess Medical Center

View Details

Sanjay Bhagani, BSc, FRCP
Consultant Physician in Infectious Diseases/HIV Medicine and General (internal) Medicine, Royal Free Hospital

View Details

Daniel Kuritzkes, MD
Brigham and Women's Hospital; Harvard Medical School,
United States

Conflict of Interest Disclosure
Receipt of grants/research support from Atea, Gilead, Merck, and ViiV
Receipt of honoraria or consultation fees from Abpro, Atea, Decoy, Gilead, GlaxoSmithKline, Merck, Novartis, Rigel, ViiV

View Details

Long-term complications of COVID-19

Carlos del Rio, MD
Emory School of Medicine & Grady Health System,
United States

Conflict of interest disclosureCarlos del Rio has received honoraria / consultation fees from Sanofi-Pasteur

References
US CDC - Post-COVID Conditions https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html#:~:text=Post%2DCOVID%20conditions%20are%20a,can%20have%20post%2DCOVID%20conditions.

UK Office for National Statistics - Prevalence of Ongoing Symptoms Following COVID-19 infection in the UK https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4june2021
COVID Symptom Study https://covid.joinzoe.com/